Financials

News Discussions Technicals Seasonals

6620 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Handa Pharmaceuticals, Inc. engages in the research, development, design, and sale of pharmaceutical business. It focuses on the development of niche drug. It offers 505(b)2 new drugs, high-tech generic drugs and other biotechnology services. The company was founded by Yu Ling Fang on May 8, 2014 and is headquartered in Tainan, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

6620 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company